Oscar Health, Inc. (OSCR) shares surged 6.00% during pre-market trading on Tuesday, as investors looked past a disappointing fourth-quarter performance and focused on the company's optimistic financial guidance for 2026 and a newly secured credit facility.

The healthcare technology firm reported Q4 2025 revenue of $2.81 billion, missing analyst estimates of $3.12 billion, and a net loss of $352.61 million. The medical loss ratio also rose sharply to 95.4%. However, the market reaction turned positive as Oscar Health projected a significant turnaround for the full year 2026, forecasting revenue between $18.7 billion and $19.0 billion and earnings from operations in the range of $250 million to $450 million.

Further bolstering investor sentiment was the announcement that the company entered into a $475 million secured revolving credit facility on February 6, 2026. Management stated this move strengthens the balance sheet and provides flexibility to fuel long-term growth, positioning the company to return to profitability in 2026.